Baotou Dongbao Bio-Tech Co Ltd - Asset Resilience Ratio

Latest as of December 2023: -1.38%

Baotou Dongbao Bio-Tech Co Ltd (300239) has an Asset Resilience Ratio of -1.38% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Baotou Dongbao Bio-Tech Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥-37.84 Million

≈ $-5.54 Million USD Cash + Short-term Investments

Total Assets

CN¥2.74 Billion

≈ $401.24 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Baotou Dongbao Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. See 300239 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Baotou Dongbao Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300239 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-37.84 Million	-1.38%
Total Liquid Assets	CN¥-37.84 Million	-1.38%

Asset Resilience Insights

Limited Liquidity: Baotou Dongbao Bio-Tech Co Ltd maintains only -1.38% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Baotou Dongbao Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Baotou Dongbao Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Baotou Dongbao Bio-Tech Co Ltd (None–None)

The table below shows the annual Asset Resilience Ratio data for Baotou Dongbao Bio-Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Baotou Dongbao Bio-Tech Co Ltd

SHE:300239 China Drug Manufacturers - Specialty & Generic

Market Cap

$475.16 Million

CN¥3.25 Billion CNY

Market Cap Rank

#12671 Global

#3747 in China

Share Price

CN¥5.47

Change (1 day)

+2.24%

52-Week Range

CN¥4.73 - CN¥6.63

All Time High

CN¥9.53